Drug Delivery

Simpler drug delivery through capsule-based inhalation

10-Dec-2018 By Ben Hargreaves

Delivery by inhalation could be an easier way to deliver therapies in areas such as oncology, suggested ACG’s development manager.

Shouldering the responsibility: Male birth control absorbed through skin

05-Dec-2018 By Maggie Lynch

A clinical trial has begun to test the safety and efficacy of male birth control in a drug delivered through application on the arms and shoulders.

Q&A

Biologics delivery tech could accelerate wound healing by 80%, says Ilya Pharma

03-Dec-2018 By Flora Southey

The Swedish biotech’s lead candidate, ILP-100, is designed to continuously deliver biological drugs to the wound surface for approximately one hour.

First generic EpiPen enters the market at half the cost

29-Nov-2018 By Maggie Lynch

Teva’s EpiPen generic will reach market at a cost of $300 per pack, which matches the price of Mylan’s own generic version.

EU CHMP gives positive opinion on first oral treatment for sleeping sickness

26-Nov-2018 By Maggie Lynch

EMA’s CHMP gives positive opinion on treatment for sleeping sickness developed by Sanofi and DNDi, after the rediscovery of lead compound.

Q&A

An easy pill to swallow: Colorcon tech targets the old, young, and pill-fatigued

26-Nov-2018 By Flora Southey

Swallowability is a recognised and growing patient problem, according to Colorcon’s general manager of film coatings, Kelly Boyer.

US FDA approves oral film formulation for treatment of rare seizure syndrome

12-Nov-2018 By Maggie Lynch

FDA approves first and only oral film formulation drug for seizures associated with Lennox-Gastaut syndrome.

Gene therapy de-coded: Utilizing mRNA ‘programming language’ for therapy production

02-Nov-2018 By Maggie Lynch

A study published by graduate students at MIT showed that a synthetic mRNA-based ‘programming language’ can control protein expression in gene therapy.

Halozyme licenses drug-delivery technology to Roche for $25m upfront

31-Oct-2018 By Maggie Lynch

Halozyme will provide its drug-delivery technology, Enhanze, to Roche to be used in the development of an undisclosed clinical stage target.

Report: US FDA guidance on complex generics to boost ANDAs in India

29-Oct-2018 By Flora Southey

The FDA’s recent guidance on complex generics ‘increases clarity’ for Indian drugmakers targeting the US market, according to India Ratings and Research.

Novartis spends $2.1bn on candidate with blockbuster potential

23-Oct-2018 By Maggie Lynch

Novartis will acquire Endocyte for $2.1bn, with the core of the deal centering on the latter’s experimental therapy for prostate cancer.

US FDA approves Pfizer’s PARP inhibitor for metastatic breast cancer

23-Oct-2018 By Maggie Lynch

The FDA approved Pfizer’s therapy for metastatic breast cancers, after clinical trials showed strong progression-free survival rates.

Q&A

Rexahn combines small and large molecules with Keytruda collab

22-Oct-2018 By Flora Southey

Rexahn Pharmaceuticals will combine its small molecule compound RX-5902 with Merck’s anti-PD-therapy, Keytruda, to evaluate its efficacy in patients with metastatic triple negative breast cancer.

Recipharm-made Parkinson’s treatment approved in Sweden

10-Oct-2018 By Flora Southey

A Swedish company’s combination gel and pump delivery system, Lecigon, has received regulatory approval for the treatment of patients with advanced Parkinson’s disease.

Q&A

Nemaura to debut 48-hour transdermal pain patch

03-Oct-2018 By Ben Hargreaves

Ahead of the CPhI Worldwide in Madrid next week, Nemaura announced that it would be showcasing its newly developed 48-hour diclofenac transdermal patch and would be linking up with an unnamed global pharma company to develop three new products.